Invitation to tender for Investigational Medicinal Product (IMP) Support – TOCSINS
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
Published
14 Nov 2025
Description
The purpose of this project is to appoint a supplier to handle the receipt of clinical trial Investigational Medicinal Product (IMP) from manufacturer, import, labelling, and distribution to the in-country sites/teams. The trial will be running in Brazil and Ghana and involves two oral drugs. Initial dose will be delivered to remote community clinic or ambulance vehicle (field) and subsequent doses stored and given from the hospital site during the participant admission. To view this notice, please click here: https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=978196522
Scope
- Reference
- LW140
- Commercial tool
- Standalone contract
- Contract dates
- 01 Aug 2025 to 31 Jul 2028Possible extension to 31 Jul 2030
6.3.The Contract may be extended beyond the Initial Term on a maximum of 2 (two) occasions, for a period of up to 1 (one) year on each occasion (each a "Renewal Period") at LSTM's sole discretion, by LSTM giving the Contractor not less than 1 (one) months' notice prior to the expiry of the Initial Term or the Renewal Period (as applicable).
- CPV classifications
- 336980007992000079921000
- Contract locations
- BR, BrazilGH, GhanaNorth West England, United Kingdom
- Particular suitability
- Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| As stated in Tender documentation | — | price | 30.00% |
| As stated in Tender documentation | — | quality | 70.00% |
Participation
Conditions suppliers must meet to bid.
n/a
Submission & procedure
- Procedure
- Open procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—